Group One Trading’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.2K | Sell |
214
-21,997
| -99% | -$3.8M | ﹤0.01% | 5517 |
|
|
2025
Q4 | $4.06M | Sell |
22,211
-9,492
| -30% | -$1.33M | 0.01% | 1685 |
|
|
2025
Q3 | $3.85M | Sell |
31,703
-4,825
| -13% | -$544K | 0.01% | 1722 |
|
|
2025
Q2 | $3.81M | Buy |
36,528
+11,005
| +43% | +$1.17M | 0.01% | 1547 |
|
|
2025
Q1 | $2.98M | Sell |
25,523
-18,297
| -42% | -$2.08M | 0.01% | 1480 |
|
|
2024
Q4 | $3.71M | Sell |
43,820
-6,321
| -13% | -$581K | 0.01% | 1388 |
|
|
2024
Q3 | $4.51M | Buy |
+50,141
| New | +$4.38M | 0.01% | 1076 |
|
|
2024
Q2 | – | Sell |
-35,461
| Closed | -$2.63M | – | 6707 |
|
|
2024
Q1 | $2.83M | Buy |
35,461
+20,543
| +138% | +$1.72M | 0.01% | 1239 |
|
|
2023
Q4 | $1.19M | Sell |
14,918
-5,441
| -27% | -$364K | ﹤0.01% | 2314 |
|
|
2023
Q3 | $1.42M | Sell |
20,359
-9,810
| -33% | -$733K | ﹤0.01% | 1932 |
|
|
2023
Q2 | $2.17M | Buy |
30,169
+23,473
| +351% | +$1.73M | 0.01% | 1638 |
|
|
2023
Q1 | $413K | Sell |
6,696
-119,859
| -95% | -$7.87M | ﹤0.01% | 2947 |
|
|
2022
Q4 | $9.76M | Sell |
126,555
-7,243
| -5% | -$433K | 0.02% | 750 |
|
|
2022
Q3 | $5.97M | Sell |
133,798
-113,910
| -46% | -$5.69M | 0.01% | 1036 |
|
|
2022
Q2 | $9.49M | Sell |
247,708
-56,065
| -18% | -$1.77M | 0.01% | 877 |
|
|
2022
Q1 | $12.6M | Sell |
303,773
-109,736
| -27% | -$3.4M | 0.01% | 855 |
|
|
2021
Q4 | $15.6M | Buy |
413,509
+215,264
| +109% | +$7.92M | 0.01% | 808 |
|
|
2021
Q3 | $6.53M | Buy |
198,245
+129,014
| +186% | +$5.03M | 0.01% | 1437 |
|
|
2021
Q2 | $4.67M | Buy |
69,231
+21,471
| +45% | +$1.29M | 0.01% | 1753 |
|
|
2021
Q1 | $2.7M | Buy |
47,760
+3,894
| +9% | +$274K | ﹤0.01% | 2136 |
|
|
2020
Q4 | $3.57M | Sell |
43,866
-1,936
| -4% | -$145K | 0.01% | 1556 |
|
|
2020
Q3 | $3.26M | Sell |
45,802
-5,947
| -11% | -$463K | 0.01% | 1211 |
|
|
2020
Q2 | $4.26M | Buy |
+51,749
| New | +$3.98M | 0.02% | 915 |
|
|
2020
Q1 | – | Sell |
-50,431
| Closed | -$4.11M | – | 5240 |
|
|
2019
Q4 | $5.21M | Sell |
50,431
-40,206
| -44% | -$1.62M | 0.04% | 663 |
|
|
2019
Q3 | $1.83M | Buy |
90,637
+30,359
| +50% | +$780K | 0.01% | 1271 |
|
|
2019
Q2 | $1.55M | Buy |
60,278
+5,354
| +10% | +$107K | 0.01% | 1279 |
|
|
2019
Q1 | $782K | Buy |
54,924
+44,830
| +444% | +$416K | 0.01% | 1586 |
|
|
2018
Q4 | $28K | Sell |
10,094
-3,101
| -24% | -$10.2K | ﹤0.01% | 3852 |
|
|
2018
Q3 | $46K | Buy |
13,195
+3,460
| +36% | +$10.3K | ﹤0.01% | 4008 |
|
|
2018
Q2 | $31K | Sell |
9,735
-29,349
| -75% | -$91K | ﹤0.01% | 4193 |
|
|
2018
Q1 | $96K | Buy |
39,084
+32,386
| +484% | +$97K | ﹤0.01% | 3275 |
|
|
2017
Q4 | $38K | Buy |
+6,698
| New | +$33.8K | ﹤0.01% | 3863 |
|
Other funds holding AXSM
VPM
VCM
DTC
Group One Trading's AXSM Position: Q1 2026 in Review
Group One Trading reduced its Axsome Therapeutics (AXSM) stake by 99% in Q1 2026, selling an estimated $3.8M and leaving 214 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5517.
Group One Trading first reported a position in AXSM in Q4 2017 and has held it in 32 quarters since. The position peaked at $15.6M in Q4 2021. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.
- Group One Trading held 214 shares of Axsome Therapeutics worth $36.2K as of Q1 2026.
- Group One Trading sold 21,997 Axsome Therapeutics shares in Q1 2026, an estimated $3.8M.
- Axsome Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5517 holding.
- Group One Trading first reported a position in Axsome Therapeutics in Q4 2017 and has held it in 32 quarters since.
- Group One Trading's Axsome Therapeutics position peaked at $15.6M in Q4 2021.
- 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.